Literature DB >> 27233600

Hepcidin inhibition on the effect of osteogenesis in zebrafish.

Yu Jiang1, Yilin Yan2, Xiao Wang3, Guoxing Zhu4, You-Jia Xu5.   

Abstract

Iron overload, as a risk factor for osteoporosis, can result in the up-regulation of Hepcidin, and Hepcidin knockout mice display defects in their bone microarchitecture. However, the molecular and genetic mechanisms underlying Hepcidin deficiency-derived bone loss remain unclear. Here, we show that hepcidin knockdown in zebrafish using morpholinos leads to iron overload. Furthermore, a mineralization delay is observed in osteoblast cells in hepcidin morphants, and these defects could be partially restored with microinjection of hepcidin mRNA. Quantitative real-time PCR analyses revealed the osteoblast-specific genes alp, runx2a, runx2b, and sp7 in morphants are down-regulated. Furthermore, we confirmed qRT-PCR results by in situ hybridization and found down-regulated genes related to osteoblast function in hepcidin morphants. Most importantly, we revealed that hepcidin was capable of removing whole-body iron which facilitated larval recovery from the reductions in bone formation and osteogenesis induced by iron overload.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepcidin; Iron overload; Morpholino; Zebrafish

Mesh:

Substances:

Year:  2016        PMID: 27233600     DOI: 10.1016/j.bbrc.2016.05.118

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Identification of Common Pathogenic Pathways Involved in Hemochromatosis Arthritis and Calcium Pyrophosphate Deposition Disease: a Review.

Authors:  Elizabeth Mitton-Fitzgerald; Claudia M Gohr; Charlene M Williams; Ann K Rosenthal
Journal:  Curr Rheumatol Rep       Date:  2022-02-10       Impact factor: 4.592

2.  Iron excess upregulates SPNS2 mRNA levels but reduces sphingosine-1-phosphate export in human osteoblastic MG-63 cells.

Authors:  L Peltier; C Bendavid; T Cavey; M-L Island; M Doyard; P Leroyer; C Allain; M De Tayrac; M Ropert; O Loréal; P Guggenbuhl
Journal:  Osteoporos Int       Date:  2018-05-03       Impact factor: 4.507

Review 3.  Clinical Impact and Cellular Mechanisms of Iron Overload-Associated Bone Loss.

Authors:  Viktória Jeney
Journal:  Front Pharmacol       Date:  2017-02-21       Impact factor: 5.810

Review 4.  Applications of Metals for Bone Regeneration.

Authors:  Kristina Glenske; Phil Donkiewicz; Alexander Köwitsch; Nada Milosevic-Oljaca; Patrick Rider; Sven Rofall; Jörg Franke; Ole Jung; Ralf Smeets; Reinhard Schnettler; Sabine Wenisch; Mike Barbeck
Journal:  Int J Mol Sci       Date:  2018-03-12       Impact factor: 5.923

5.  Bone Formation Ability and Cell Viability Enhancement of MC3T3-E1 Cells by Ferrostatin-1 a Ferroptosis Inhibitor of Cancer Cells.

Authors:  Alireza Valanezhad; Tetsurou Odatsu; Shigeaki Abe; Ikuya Watanabe
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

Review 6.  Influence of Iron on Bone Homeostasis.

Authors:  Enikő Balogh; György Paragh; Viktória Jeney
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.